Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial

BACKGROUND: Fibroblast growth factor-23 (FGF23) regulates body phosphate homeostasis primarily by increasing phosphaturia. It also acts as a vitamin D-regulating hormone. Maternal iron deficiency is associated with perturbed expression and/or regulation of FGF23 and hence might be implicated in the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Clin Nutr
Päätekijät: Braithwaite, Vickie S, Mwangi, Martin N, Jones, Kerry S, Demir, Ayşe Y, Prentice, Ann, Prentice, Andrew M, Andang'o, Pauline E A, Verhoef, Hans
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2021
Aiheet:
Original Research Communications
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106766/
https://ncbi.nlm.nih.gov/pubmed/33675347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajcn/nqaa417
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia